Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2643-2648

  Baras, Benoît ^a,b   Benoit, Marie Ange ^a   Dupré, Loïc ^b   Poulain Godefroy, Odile ^b   Schacht, Anne Marie ^b   Capron, André ^b   Gillard, Jean ^a   Riveau, Gilles ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; POLYCAPROLACTONE; POLYGLACTIN; RECOMBINANT ENZYME; SCHISTOSOMA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTESTINE LAVAGE; INTRANASAL DRUG ADMINISTRATION; LUNG LAVAGE; MICROENCAPSULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINE PRODUCTION;

EID: 0032921895     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2643-2648.1999     Document Type: Article

References (30)

1. Balloul, J. M., J. M. Grzych, R. J. Pierce, and A. Capron. 1987. A purified 28,000 daltons protein from Schistosoma mansoni, adult worms protects rats and mice against experimental schistosomiasis. J. Immunol. 138:3448-3453.
2. Balloul, J. M., P. Sondermayer, D. Dreyer, M. Capron, J. M. Grzych, R. J. Pierce, D. Carvallo, J. P. Lecocq, and A. Capron. 1987. Molecular cloning of a protective antigen against schistosomiasis. Nature 326:149-153.
3. Benoit, M.-A., B. Baras, O. Poulain-Godefroy, A.-M. Schacht, A. Capron, J. Gillard, and G. Riveau. 1998. Evaluation of the antibody response after oral immunization by microparticles containing an antigen from Schistosoma mansoni, p. 137-144. In A. A. Hincal and H. S. Kas (ed.), Biomedical science and technology: recent developments in pharmaceutical and medical science. Plenum Press, New York, N.Y.
4. Benoit, M.-A., O. Poulain-Godefroy, B. Baras, B. B. C. Youan, G. Riveau, J. Gillard, and A. Capron. 1997. Study on the antigenicity of microencapsulated Sm28-GST from Schistosoma mansoni. Proc. Int. Symp. Control. Release Bioact. Mater. 24:817-818.
5. Bloom, B. R 1989. Vaccines for the third world. Nature 342:115-120.
6. Boulanger, D., G. D. F. Reid, R. F. Sturrock, I. Wolowczuk, J. M. Balloul, D. Grezel, R. J. Pierce, M. F. Otieno, S. Guerret, J. A. Grimaud, A. E. Butterworth, and A. Capron. 1991. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 13:473-490.
7. Cleland, J. L. 1995. Design and production of single-immunization vaccines using polylactide polyglycolide microsphere system, p. 439-462. In M. P. Powell and M. J. Newman (ed.), Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
8. Delgado, V., and D. J. McLaren. 1990. Evidence for enhancement of IgG1 subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. Parasite Immunol. 12:15-32.
9. Eldridge, J. H., C. J. Hammond, and J. A. Meulbroek. 1990. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release 11:205-214.
10. Eldridge, J. H., J. K. Staas, J. A. Meulbroek, J. R. McGhee, T. R. Tice, and R. M. Gilley. 1991. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:287-294
11. Gombotz, W. R., and D. K. Pettit 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconj. Chem. 6:332-351.
12. Grezel, D., M. Capron, J. M. Grzych, J. Fontaine, J. P. Lecocq, and A. Capron. 1993. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Eur. J. Immunol. 23:454-460.
13. Grzych, J.-M., D. Grezel, C. B. Xu, J.-L. Neyrinck, M. Capron, J. H. Ouma, A. E. Butterworth, and A. Capron. 1993. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J. Immunol. 150:527-535.
14. Habig, W. H., and W. B. Jakoby. 1981. Assays for differentiation of glutathione S-transferase. Methods Enzymol. 77:398-405.
15. Hora, M. S., R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley, and M. E. Hudson. 1990. Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm. Res. 7:1190-1194.
16. Ivanoff, N., N. Phillips, A.-M. Schacht, C. Heydari, A. Capron, and G. Riveau. 1996. Mucosal vaccination against schistosomiasis using liposome-associated Sm28 kDa glutathione S-transferase. Vaccine 14:1123-1131.
17. Jameela, S. R., N. Suma, A. Misra, R. Raghuvanshi, S. Ganga, and A. Jayakrishnan. 1996. Poly(ε-caprolactone) microspheres as vaccine carrier. Curr. Sci. 70:569-671.
18. Jeffery, H., S. S. Davis, and D. T. O'Hagan. 1993. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10:362-367.
19. Kremer, L., G. Riveau, A. Baulard, A. Capron, and C. Locht. 1996. Neutralizing antibody responses elicited in mice immunized with recombinant Bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase. J. Immunol. 156:4309-4317.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamshchikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
22. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
23. Mestecky, J., Z. Moldoveanu, M. Novak, and R. W. Compans. 1994. Mucosal immunity and strategies for novel microbial vaccines. Acta Paediatr. Jpn. 36:537-544.
24. Mielcarek, N., J. Cornette, A.-M. Schacht, R. J. Pierce, C. Locht, A. Capron, and G. Riveau. 1997. Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. Infect. Immun. 65:544-550.
25. Moldoveanu, Z., M. Novak, W. Huang, R. M. Gilley, J. K. Staas, D. Schafer, R. W. Compans, and J. Mestecky. 1993. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167:84-90.
26. O'Hagan, D. T., J. P. McGee, J. Holmgren, A. M. Mowat, A. M. Donache, K. H. G. Mills, W. Gaisford, D. Rahman, and S. J. Challacombe. 1993. Biodegradable microparticles for oral immunization. Vaccine 11:149-154.
27. Okada, H., Y. Inoue, T. Heya, H. Ueno, Y. Ogawa, and H. Toguchi. 1991. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm. Res. 8:787-791.
28. Taylor, J. R., A. Vidal, G. Torpier, D. J. Meyer, C. Roitsch, J. M. Balloul, C. Southan, P. Sondermeyer, S. Pemble, J. P. Lecocq, A. Capron, and B. Ketterer. 1988. The glutathione transferase activity and tissue distribution of a cloned Mr28K protective antigen of Schistosoma mansoni. EMBO J. 7:465-472.
29. Tseng, J., J. L. Komisar, R. N. Trout, R. E. Hunt, J. Yok-Jen Chen, A. J. Johnson, L. Pitt, and D. L. Ruble. 1995. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect. Immun. 63:2880-2885.
30. Xu, C. B., C. Verwaerde, J. M. Grzych, J. Fontaine, and A. Capron. 1991. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur. J. Immunol. 150:940-949.